Search results for Jnj

Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

JNJ (NYSE: JNJ) to release Q1 earnings before bell on April 14. Analysts expect $2.67/share & $23.6B revenue. FDA approves TECNIS PureSee lens. Latest Ratings for JNJ Date...

Johnson & Johnson (JNJ) Q1 2026 Earnings Call Transcript

Johnson & Johnson (JNJ) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Johnson & Johnson to Participate in the Bernstein's 42nd Annual Strategic Decisions Conference

Johnson & Johnson (NYSE: JNJ) will present at the Bernstein's 42 nd Annual Strategic Decisions Conference on Wednesday, May 27 th, 2026. Management will participate in a Fires...

J&J gets naming rights to the Johnson & Johnson Exchange at the New Jersey Innovation Hub, Powered by Portal Inn...

Portal Innovations, in partnership with the New Brunswick Development Corporation (DEVCO) and HELIX, announced May 19 that Johnson & Johnson received naming rights to the Johns...

Johnson & Johnson: Success In Multiple Myeloma Underpins $25B In Growth By 2030

Johnson & Johnson Q2 Earnings Review: Why You Should Be Buying The Stock Today

Two Paths to Growth: Johnson & Johnson vs AbbVie

Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Today's Market

Johnson & Johnson sells products that are necessities, not just nice-to-haves.

Why Johnson & Johnson (JNJ) Still Fits a Defensive Growth Case

Could Buying This Dividend Pharma Stock Today Set You Up for Life?

This Dividend King drug maker's dividend yield is roughly twice that of the S&P 500 index.

Johnson & Johnson Benefits are no longer competitive.

Johnson & Johnson Benefits are no longer competitive. Anonymous (not verified) Thu, 04/09/2026 - 20:03 field_thread_url https://cafepharma.com/boards/t...

<![CDATA[Johnson & Johnson’s Experience Navigating The Commissioner’s National Priority Voucher Program]]>

INLEXZOâ„¢ (gemcitabine intravesical system) Assigned Permanent Billing Code, Supporting Access for Patients with Certai...

Johnson & Johnson (NYSE:JNJ) today announced the permanent Healthcare Common Procedure Coding System (HCPCS) J-code for INLEXZOв„ў (gemcitabine intravesical system) is now in e...

Johnson & Johnson Joins TrumpRX

Three name-brand diabetes drugs and a blood thinner are now available at a discount on the government platform and J&J’s own website.

Johnson & Johnson names Koors VP, investor relations

New Brunswick-based Johnson & Johnson has appointed Ryan Koors to vice president, investor relations, effective May 7. He will report to the company’s Executive Vice President...

3rd Circ. Upholds J&J Injunction Bid Loss In Biosimilar Fight

The Third Circuit on Tuesday ruled that a Johnson & Johnson subsidiary couldn't justify its bid for an order blocking Samsung Bioepis from paving the way for a Cigna unit to la...

Why We Increased The Position In Johnson & Johnson

This "Boring" Dividend King Is Quietly Turning Into a Growth Machine

The blue chip dividend stock is quietly growing again as a streamlined company.

Jim Cramer on Johnson & Johnson: “If It Gets Blasted, Try to Get Some”

Jim Cramer on Johnson & Johnson: “If It Gets Blasted, Try to Get Some”

<![CDATA[Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson &...

Cerenovus Division

Cerenovus Division Anonymous (not verified) Sun, 05/03/2026 - 14:19 field_thread_url https://cafepharma.com/boards/threads/cerenovus-division.685354/...

Laser Photonics Expands into Precision Medical Device Manufacturing with Custom Laser Drilling System Order from Johnson...

$250K Development System Order from Johnson & Johnson Represents Entry into Medical Device Manufacturing; Successful Validation Could Enable Broader Deployment Across Manufactu...